Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 31 July 2026.
The financing was led by the T&J Meyer Family Foundation and will fund pivotal FDA registration trials for the company's HIVEC treatment.
"Combat Medicalis leading the development and clinical use of device assisted therapies with potential to disrupt current treatment standards. With systems in wide clinical use and already impacting patient outcomes, we are excited to support the company as HIVEC progresses through clinical trials."
Ribbit has led a £13m Series A investment into Outpost to scale its cross-border compliance and payments infrastructure.
"Brexit, shifting tariffs, and regulatory fragmentation have made cross-border commerce more hostile than at any point in the last two decades. Merchants are forced to choose between spending millions on consultants and local entity setup, or carrying enormous risk on payments and compliance. Outpost exists to eliminate that trade-off. We’ve built the only infrastructure that handles everything from local payment processing to full tax liability, allowing companies to treat international expansion with the same ease as selling locally."
The financing round was led by Soulmates Ventures with backing from several new and existing investors.
"Antiverse is tackling one of the most technically demanding problems in drug discovery. The team’s ability to reduce the development time for de novo therapeutic-grade antibodies in a defined domain to under four months is a significant scientific and operational achievement. This capability, combined with the AI-driven design and in-house labs, positions Antiverse on track to become a global leader and the go-to developer of antibody therapies for the most elusive disease targets in medicine"
.png)
The Series A was led by GV with participation from Accel, Northzone, and other backers.
"Magic happens when companies get the exact technology they need. Enterprises are desperate to capitalize on the AI coding revolution, but nobody has built a product that reflects their reality – complex systems, strict standards, and global scale. SolveAI puts the power to build software directly in the hands of the people closest to the problems, without compromising security or compliance. Think about all the things you could achieve if your IT team could be everywhere at once: SolveAI makes this a reality."
Chalfen Ventures and Begin Capital join existing backers to support the rollout of SurrealDB 3.0.
"This fresh investment demonstrates a growing level of excitement for our category-defining, developer-friendly database. Chalfen Ventures and Begin Capital have joined this round due to our strong momentum in real-world usage, and clear path to large-scale production."
